
Precigen PGEN
€ 4.29
5.32%
Precigen DIO | PGEN
DIO Jährlich Precigen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 95.7 | 124 | 119 | 125 | 152 | 489 | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 489 | 95.7 | 184 |
DIO anderer Aktien in der Pharmaeinzelhändler
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MediWound Ltd.
MDWD
|
35.4 | $ 13.81 | -2.13 % | $ 376 M | ||
|
ANI Pharmaceuticals
ANIP
|
150 | $ 71.09 | -0.22 % | $ 1.43 B | ||
|
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.24 | -6.06 % | $ 330 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
129 | $ 7.66 | 1.73 % | $ 1.61 B | ||
|
Coherus BioSciences
CHRS
|
97.5 | $ 0.58 | -8.97 % | $ 67.9 M | ||
|
Arcutis Biotherapeutics
ARQT
|
185 | $ 28.37 | 3.6 % | $ 3.61 B | ||
|
Cellectis S.A.
CLLS
|
23.3 | $ 1.35 | 21.62 % | $ 135 M | ||
|
Alkermes plc
ALKS
|
353 | $ 47.94 | 3.16 % | $ 7.9 B | ||
|
Novartis AG
NVS
|
130 | $ 160.35 | -1.79 % | $ 311 B | ||
|
Aurinia Pharmaceuticals
AUPH
|
474 | $ 16.22 | -0.49 % | $ 2.18 B | ||
|
Collegium Pharmaceutical
COLL
|
181 | $ 24.8 | 1.35 % | $ 785 M | ||
|
Amarin Corporation plc
AMRN
|
637 | $ 11.68 | -0.64 % | $ 4.85 B | ||
|
ImmuCell Corporation
ICCC
|
185 | $ 10.19 | -0.7 % | $ 92 M | ||
|
Agios Pharmaceuticals
AGIO
|
1.74 K | $ 32.84 | 3.38 % | $ 1.9 B | ||
|
Abeona Therapeutics
ABEO
|
265 | $ 2.35 | -4.28 % | $ 124 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
416 | $ 18.38 | 0.55 % | $ 3.09 B | ||
|
Atossa Therapeutics
ATOS
|
42.6 | $ 2.04 | -4.67 % | $ 17.6 M | ||
|
ADC Therapeutics SA
ADCT
|
203 | $ 1.6 | 5.3 % | $ 203 M | ||
|
Harmony Biosciences Holdings
HRMY
|
11.6 | $ 34.22 | 2.0 % | $ 1.97 B | ||
|
Ardelyx
ARDX
|
989 | $ 3.14 | 4.15 % | $ 757 M | ||
|
Akebia Therapeutics
AKBA
|
147 | $ 0.57 | 5.2 % | $ 147 M |